Cardiology News and Research

Latest Cardiology News and Research

Sleep disorders may increase risk of cardiovascular and metabolic diseases

Many Americans will lose an hour of sleep on March 14, the first day of daylight-saving time, when clocks are set ahead one hour at 2 a.m. local standard time—making it harder to wake up, causing difficulty in staying alert and increasing the chance of sleepy-driving car crashes.

11 Mar 2010

Lincoln, Kucinich weigh in on health bill votes

The Associated Press/The Washington Times: Sen. Blanche Lincoln, D-Ark., "insisted Tuesday she remained opposed to pushing a health care bill through the Senate with a simple majority vote, despite saying she wanted to see what was in the legislation." Lincoln "said those comments didn't represent a change of heart on her stance against the controversial majority-vote procedure known as 'reconciliation.' 'I don't support reconciliation. All I said was I want to see what's in it,' Lincoln told reporters outside the Senate floor. She walked quickly into a senators-only area without elaborating" (Werner, 3/9).

11 Mar 2010

Cardiologists to highlight capabilities of InfraReDx' LipiScan Coronary Imaging System at ACC.10 and i2 Summit

InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company's LipiScan™ Coronary Imaging System will be highlighted in multiple sessions during the 59th Annual Scientific Session of the American College of Cardiology.

11 Mar 2010

Cogent Healthcare, Seton Medical Center to develop exclusive hospitalist care delivery system

Cogent Healthcare today announced a new hospital medicine affiliation with 375-bed Seton Medical Center, located in Daly City, Calif., and the Daly City Hospitalist Medical Group, an existing Seton physician group, to develop a distinctive hospitalist care delivery system.

11 Mar 2010

Lithera announces positive results from Phase IIa clinical study of LIPO-102

Lithera, Inc. today announced positive results from a Phase IIa clinical study of LIPO-102, its novel injectable combination of salmeterol xinafoate (SX) and fluticasone propionate (FP) for selective, non-ablative fat reduction.

11 Mar 2010

HyperBranch Medical Technology's surgical sealants to be marketed under new name – Adherus Surgical Sealants

HyperBranch Medical Technology, Inc. announced today that it will begin to market their surgical sealants under a new product identity – Adherus Surgical Sealants.

11 Mar 2010

Eureka Genomics announces closing of $3.7M private financing round

Eureka Genomics today announced the closing of a $3.7 million private financing round whose participants included private individuals and undisclosed angel investors. The proceeds will further discovery research aimed at identifying novel microorganisms associated with specific cancers and other important diseases, as well as help grow Eureka Genomics’ high-throughput sequencing and bioinformatics service business on a global basis.

11 Mar 2010

Small study shows eprotirome decreases LDL cholesterol

People whose "bad" cholesterol and risk of future heart disease stay too high despite cholesterol-lowering statin therapy can safely lower it by adding a drug that mimics the action of thyroid hormone. In a report published in the Mar. 11, issue of the New England Journal of Medicine, Johns Hopkins and Swedish researchers say an experimental drug called eprotirome lowered cholesterol up to 32 percent in those already on statins, an effect equal to that expected from doubling the statin drug doses, without harmful side effects.

10 Mar 2010

Aastrom Biosciences treats final patient in IMPACT-DCM Phase 2 surgical clinical trial

Aastrom Biosciences, Inc., a leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today reported the final patient treatment in the company's ongoing U.S. Phase 2 surgical clinical trial designated IMPACT-DCM.

10 Mar 2010

Eprotirome lowers bad cholesterol, triglycerides and Lp(A) without statin side effects

A new drug, eprotirome, has been shown to significantly lower bad cholesterol, triglycerides and Lp(A), without the side effects that statins cause in many people. Results of a study were published today in the New England Journal of Medicine.

10 Mar 2010

TNS acquires license to Ergothioneine Transporter from University of Cologne

Total Nutraceutical Solutions, Inc. announced that the company has acquired from the University of Cologne, Cologne, Germany, an exclusive license agreement on the invention entitled “Ergothioneine Transporter,” owned by the University.

10 Mar 2010

Growth rate of nonradiologists owning or leasing PET equipment higher than radiologists

Positron Corporation. The growth rate among nonradiologists who own or lease PET equipment was far higher than radiologists between 2002 and 2007, according to a study published in the March issue of the Journal of the American College of Radiology.

10 Mar 2010

African-Americans and Hispanics are at higher risk for developing Alzheimer's and dementias

According to the Alzheimer's Association's® 2010 Alzheimer's Disease Facts and Figures, African-Americans are about two times more likely and Hispanics are about one and one-half times more likely than their white counterparts to have Alzheimer's and other dementias.

10 Mar 2010

Young women with heart attacks at higher risk of dying in hospital than men

Geisinger Health System and Yale School of Medicine investigators are researching how young people recover from heart attacks through VIRGO (Variation in Recovery: Role of Gender on Outcomes in Young AMI Patients), a research project funded by the National, Heart, Lung and Blood Institute.

10 Mar 2010

Visitors to Rockefeller Center to get unexpected lesson on Alzheimer’s disease throughout March

Throughout the month of March, visitors to Rockefeller Center in the heart of midtown Manhattan will get an unexpected lesson on Alzheimer’s disease.

10 Mar 2010

Genetic basis unknown in many children with mental retardation and developmental delays

Researchers from four laboratories that perform diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities recently identified a previously unrecognized genetic disorder.

10 Mar 2010

Early administration of metformin can prevent long-term complications of diabetes: Study

The sooner people with diabetes start taking metformin, the longer the drug remains effective, according to a Kaiser Permanente study published in the March issue of Diabetes Care, a journal of the American Diabetes Association.

10 Mar 2010

2010 Max Planck Research Award for Dr. Timothy Bromage from NYU College of Dentistry

New York University College of Dentistry's Dr. Timothy Bromage has been selected to receive the 2010 Max Planck Research Award. Dr. Bromage will collaborate with Dr. Friedemann Schrenk of Frankfurt's Senckenberg Research Institute to research the microanatomical structure of bones and teeth, and the links between metabolic states, growth rates, life spans, and biological features such as sex and body size.

10 Mar 2010

2010 European LDN Conference: LDN can be used as effective treatment for people with MS

People with MS (Multiple Sclerosis) and others suffering with a range of often debilitating inflammatory conditions such as Chronic Fatigue Syndrome and Fibromyalgia, will take heart from advances in treatment for their conditions, and will follow events at The 2nd European LDN Conference with interest.

10 Mar 2010

Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes

Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the “Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus” trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.

10 Mar 2010

Cardiology News and Research

Latest Cardiology News and Research

Sleep disorders may increase risk of cardiovascular and metabolic diseases

Lincoln, Kucinich weigh in on health bill votes

Cardiologists to highlight capabilities of InfraReDx' LipiScan Coronary Imaging System at ACC.10 and i2 Summit

Cogent Healthcare, Seton Medical Center to develop exclusive hospitalist care delivery system

Lithera announces positive results from Phase IIa clinical study of LIPO-102

HyperBranch Medical Technology's surgical sealants to be marketed under new name – Adherus Surgical Sealants

Eureka Genomics announces closing of $3.7M private financing round

Small study shows eprotirome decreases LDL cholesterol

Aastrom Biosciences treats final patient in IMPACT-DCM Phase 2 surgical clinical trial

Eprotirome lowers bad cholesterol, triglycerides and Lp(A) without statin side effects

TNS acquires license to Ergothioneine Transporter from University of Cologne

Growth rate of nonradiologists owning or leasing PET equipment higher than radiologists

African-Americans and Hispanics are at higher risk for developing Alzheimer's and dementias

Young women with heart attacks at higher risk of dying in hospital than men

Visitors to Rockefeller Center to get unexpected lesson on Alzheimer’s disease throughout March

Genetic basis unknown in many children with mental retardation and developmental delays

Early administration of metformin can prevent long-term complications of diabetes: Study

2010 Max Planck Research Award for Dr. Timothy Bromage from NYU College of Dentistry

2010 European LDN Conference: LDN can be used as effective treatment for people with MS

Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Cardiology News and Research

Latest Cardiology News and Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in